Tenax Therapeutics, Inc.TENXNASDAQ
Loading
TENX Revenue Growth (YoY Quarterly)•+0.00%
Stock Alarm Pro
Growth Metrics
Latest: Q4 2025vs Q3 2025
Revenue GrowthGross Profit GrowthEBITDA GrowthOperating Income GrowthNet Income GrowthEPS GrowthEPS Diluted GrowthWeighted Average Shares GrowthWeighted Average Shares Diluted GrowthDividends per Share Growth
+0.00%
+0.0pp
+0.00%
+0.0pp
+0.00%
+0.0pp
+0.00%
+463.9pp
+0.00%
+0.0pp
+0.00%
+0.0pp
+0.00%
+0.0pp
+156.80%
+69.0pp
+156.80%
+69.0pp
+0.00%
+0.0pp
| Metric | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 |
|---|---|---|---|---|---|
| Revenue Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Gross Profit Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EBITDA Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Income Growth | +0.00% | +0.00% | +0.00% | -463.85% | +0.00% |
| Net Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Diluted Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Weighted Average Shares Growth | +6046.87% | +2900.88% | +1920.80% | +87.80% | +156.80% |
| Weighted Average Shares Diluted Growth | +6046.87% | +2900.88% | +1920.80% | +87.80% | +156.80% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Free Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Receivables Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Inventory Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Asset Growth | +727.46% | +674.94% | +897.06% | +3.03% | +7.80% |
| Book Value per Share Growth | -81.52% | -70.70% | -42.39% | -47.31% | -58.91% |
| Debt Growth | -100.00% | -100.00% | -100.00% | +0.00% | +0.00% |
| R&D Expense Growth | +170.32% | +112.37% | +163.04% | +231.87% | +129.45% |
| SG&A Expenses Growth | +65.01% | +358.64% | +321.95% | +329.92% | +118.76% |
1 / 4